PXD047924 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Natural small molecule DP combats liver fibrosis by targeting APOL2 |
Description | Liver fibrosis is an urgent clinical problem without effective treatment. Herein, we conducted a high-content screening on a natural “privileged” diterpenoid library to identify a potent anti-liver fibrosis lead DP. Leveraging photoaffinity labeling approach, apolipoprotein L2 (APOL2), an ER-rich protein, was identified as the direct target of DP. APOL2 is mainly expressed in activated hepatic stellate cells (HSCs) and could activate HSCs to synthesize ECM proteins. It can be induced by TGF-β1 and be antagonized by DP. Mechanistically, upon TGF-β1stimulation, APOL2 binds ER Ca2+ pump SERCA2 to trigger ER stress, elevating its downstream PERK-HES1 axis to promote liver fibrosis, mildly dependent on the canonical TGF-β/Smad signaling. As a result, ablation of APOL2 significantly alleviated TGF-β1-stimulated HSCs activation, and abolished anti-fibrosis effect of DP. Our findings not only define APOL2 as a novel therapeutic target for liver fibrosis, but also highlight DP as a promising lead for treatment of this symptom. |
HostingRepository | PRIDE |
AnnounceDate | 2024-10-22 |
AnnouncementXML | Submission_2024-10-22_06:54:48.153.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Lu Gan |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-12-18 19:52:41 | ID requested | |
1 | 2024-08-13 03:12:23 | announced | |
⏵ 2 | 2024-10-22 06:54:48 | announced | 2024-10-22: Updated project metadata. |
Publication List
Gan L, Jiang Q, Huang D, Wu X, Zhu X, Wang L, Xie W, Huang J, Fan R, Jing Y, Tang G, Li XD, Guo J, Yin S, A natural small molecule alleviates liver fibrosis by targeting apolipoprotein L2. Nat Chem Biol, 21(1):80-90(2025) [pubmed] |
10.1038/s41589-024-01704-3; |
Keyword List
submitter keyword: APOL2, Anti-liver fibrosis,Natural small molecule, ER stress, HES1 |
Contact List
Sheng Yin |
contact affiliation | School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, Guangdong, P.R. China. |
contact email | yinsh2@mail.sysu.edu.cn |
lab head | |
Lu Gan |
contact affiliation | School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, 510006, Guangdong, P.R. China. |
contact email | ganlu27@mail2.sysu.edu.cn |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/08/PXD047924 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD047924
- Label: PRIDE project
- Name: Natural small molecule DP combats liver fibrosis by targeting APOL2